Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2023 | How can we improve personalised therapy for glioblastoma?

Patrick Wen • 2 Jun 2023
ASCO 2023
Brain Tumor Glioblastoma Glioma

Patrick Wen, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the challenges associated with personalizing therapy for glioblastoma. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Patrick Wen

Clinical advances in brain cancer: AZD1390 and CAR-T cells in glioma
2:19
Clinical advances in brain cancer: AZD1390 and CAR-T cells in glioma
Patrick Wen • 12 Apr 2024
ACTION: ONC201 in H3 K27M–mutant diffuse midline glioma
1:52
ACTION: ONC201 in H3 K27M–mutant diffuse midline glioma
Patrick Wen • 12 Apr 2024
Genomic predictors of adverse events in glioblastoma
1:07
Genomic predictors of adverse events in glioblastoma
Patrick Wen • 12 Apr 2024
Clinical advances in the management of gliomas
2:48
Clinical advances in the management of gliomas
Patrick Wen • 12 Apr 2024

Related Videos

Phase I trial of fb-PMT safety and tolerability in recurrent glioblastoma
3:54
Phase I trial of fb-PMT safety and tolerability in recurrent glioblastoma
Nicholas Blondin • 4 Jun 2026
Promising brain tumor trials at ASCO: MAGMA and ROADS
3:32
Promising brain tumor trials at ASCO: MAGMA and ROADS
Nicholas Blondin • 4 Jun 2026
MTAP deletions and co-mutational landscape in primary CNS tumors via WGS
2:37
MTAP deletions and co-mutational landscape in primary CNS tumors via WGS
Martin Hojgaard • 29 May 2026
What does the future hold for live cell vaccines in treating brain tumors?
1:25
What does the future hold for live cell vaccines in treating brain tumors?
David Giles • 13 Mar 2026
The content of VJOncology is intended for healthcare professionals